PortfoliosLab logoPortfoliosLab logo
ZTS vs. ELAN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZTS vs. ELAN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zoetis Inc. (ZTS) and Elanco Animal Health Incorporated (ELAN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZTS achieves a -37.61% return, which is significantly lower than ELAN's 16.53% return.


ZTS

1D
1.66%
1M
4.05%
6M
-37.38%
YTD
-37.61%
1Y
-46.55%
3Y*
-24.28%
5Y*
-16.61%
10Y*
5.43%
ALL TIME*
7.80%

ELAN

1D
-0.34%
1M
5.48%
6M
9.51%
YTD
16.53%
1Y
91.23%
3Y*
30.12%
5Y*
-6.28%
10Y*
ALL TIME*
-2.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$130.91M$117.38M$140.58M
$391.98M$415.23M$596.57M

ZTS vs. ELAN - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ZTS
Zoetis Inc.
-37.61%-21.75%-16.63%35.91%-39.51%48.26%25.76%55.71%-3.84%
ELAN
Elanco Animal Health Incorporated
16.53%86.87%-18.72%21.93%-56.94%-7.47%4.14%-6.60%-2.23%

Correlation

The correlation between ZTS and ELAN is 0.45, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.45

Correlation (3Y)
Balances recent behavior with more history.

0.42

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.48

Correlation (All Time)
Calculated using the full available price history since Sep 20, 2018

0.45

Fundamentals

Market Cap

ZTS:

$32.40B

ELAN:

$13.18B

EPS

ZTS:

$6.08

ELAN:

-$0.48

PS Ratio

ZTS:

3.53

ELAN:

2.69

PB Ratio

ZTS:

10.10

ELAN:

2.05

Total Revenue (TTM)

ZTS:

$9.51B

ELAN:

$4.89B

Gross Profit (TTM)

ZTS:

$6.73B

ELAN:

$2.42B

EBITDA (TTM)

ZTS:

$3.95B

ELAN:

$755.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZTS vs. ELAN — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ZTS
ZTS Risk / Return Rank: 44
Overall Rank
ZTS Sharpe Ratio Rank: 11
Sharpe Ratio Rank
ZTS Sortino Ratio Rank: 55
Sortino Ratio Rank
ZTS Omega Ratio Rank: 22
Omega Ratio Rank
ZTS Calmar Ratio Rank: 1010
Calmar Ratio Rank
ZTS Martin Ratio Rank: 44
Martin Ratio Rank

ELAN
ELAN Risk / Return Rank: 9191
Overall Rank
ELAN Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
ELAN Sortino Ratio Rank: 9191
Sortino Ratio Rank
ELAN Omega Ratio Rank: 9191
Omega Ratio Rank
ELAN Calmar Ratio Rank: 9090
Calmar Ratio Rank
ELAN Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ZTS vs. ELAN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zoetis Inc. (ZTS) and Elanco Animal Health Incorporated (ELAN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZTSELANDifference
Sharpe ratioReturn per unit of total volatility

-3.38

Sortino ratioReturn per unit of downside risk

-4.55

Omega ratioGain probability vs. loss probability

0.72

1.37

-0.65

Calmar ratioReturn relative to maximum drawdown

-0.86

3.56

-4.42

Martin ratioReturn relative to average drawdown

-1.59

10.97

-12.56

ZTS vs. ELAN - Sharpe Ratio Comparison

The current ZTS Sharpe Ratio is -1.27, which is lower than the ELAN Sharpe Ratio of 2.11. The chart below compares the historical Sharpe Ratios of ZTS and ELAN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZTS vs. ELAN - Drawdown Comparison

The maximum ZTS drawdown since its inception was -69.48%, smaller than the maximum ELAN drawdown of -78.00%. Use the drawdown chart below to compare losses from any high point for ZTS and ELAN.


Loading charts...

Drawdown Indicators


ZTSELANDifference

Max Drawdown

Largest peak-to-trough decline

-69.48%

-78.00%

+8.52%

Max Drawdown (1Y)

Largest decline over 1 year

-53.60%

-26.23%

-27.37%

Max Drawdown (3Y)

Largest decline over 3 years

-62.99%

-56.10%

-6.89%

Max Drawdown (5Y)

Largest decline over 5 years

-69.48%

-77.81%

+8.33%

Max Drawdown (10Y)

Largest decline over 10 years

-69.48%

Current Drawdown

Current decline from peak

-66.94%

-28.19%

-38.75%

Average Drawdown

Average peak-to-trough decline

-15.36%

-39.65%

+24.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.91%

8.49%

+20.42%

Volatility

ZTS vs. ELAN - Volatility Comparison

The current volatility for Zoetis Inc. (ZTS) is 6.89%, while Elanco Animal Health Incorporated (ELAN) has a volatility of 7.39%. This indicates that ZTS experiences smaller price fluctuations and is considered to be less risky than ELAN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZTSELANDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.89%

7.39%

-0.50%

Volatility (6M)

Calculated over the trailing 6-month period

32.29%

33.69%

-1.40%

Volatility (1Y)

Calculated over the trailing 1-year period

36.31%

44.27%

-7.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.02%

45.85%

-16.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.20%

44.25%

-17.05%

Dividends

ZTS vs. ELAN - Dividend Comparison

ZTS's dividend yield for the trailing twelve months is around 2.70%, while ELAN has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ELAN
Elanco Animal Health Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ZTS
Zoetis Inc.
2.70%1.59%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%

Financials

ZTS vs. ELAN - Financials Comparison

This section allows you to compare key financial metrics between Zoetis Inc. and Elanco Animal Health Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

ZTS vs. ELAN - Profitability Comparison

The chart below illustrates the profitability comparison between Zoetis Inc. and Elanco Animal Health Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

ZTS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Zoetis Inc. reported a gross profit of 1.62B and revenue of 2.26B. Therefore, the gross margin over that period was 71.7%.

ELAN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Elanco Animal Health Incorporated reported a gross profit of 785.00M and revenue of 1.37B. Therefore, the gross margin over that period was 57.3%.

ZTS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Zoetis Inc. reported an operating income of 853.00M and revenue of 2.26B, resulting in an operating margin of 37.7%.

ELAN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Elanco Animal Health Incorporated reported an operating income of 307.00M and revenue of 1.37B, resulting in an operating margin of 22.4%.

ZTS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Zoetis Inc. reported a net income of 601.00M and revenue of 2.26B, resulting in a net margin of 26.6%.

ELAN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Elanco Animal Health Incorporated reported a net income of 57.00M and revenue of 1.37B, resulting in a net margin of 4.2%.


Frequently Asked Questions


ZTS and ELAN have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ELAN has higher volatility (7.39%) compared to ZTS (6.89%). In terms of maximum drawdown, ZTS dropped -69.48% vs ELAN's -78.00%.

ELAN currently has the higher Sharpe Ratio (2.11 vs -1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZTS and ELAN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer